Your browser doesn't support javascript.
loading
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo, Jianmin; Dowell, Alexander C; Pearce, Hayden; Verma, Kriti; Long, Heather M; Begum, Jusnara; Aiano, Felicity; Amin-Chowdhury, Zahin; Hoschler, Katja; Brooks, Tim; Taylor, Stephen; Hewson, Jacqueline; Hallis, Bassam; Stapley, Lorrain; Borrow, Ray; Linley, Ezra; Ahmad, Shazaad; Parker, Ben; Horsley, Alex; Amirthalingam, Gayatri; Brown, Kevin; Ramsay, Mary E; Ladhani, Shamez; Moss, Paul.
Afiliación
  • Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Dowell AC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Pearce H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Verma K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Long HM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Begum J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Aiano F; Immunisation and Countermeasures Division, National Infection Service, London, UK.
  • Amin-Chowdhury Z; Immunisation and Countermeasures Division, National Infection Service, London, UK.
  • Hoschler K; Immunisation and Countermeasures Division, National Infection Service, London, UK.
  • Brooks T; Immunoassay Laboratory, National Infection Service, Porton Down, UK.
  • Taylor S; Immunoassay Laboratory, National Infection Service, Porton Down, UK.
  • Hewson J; Immunisation and Countermeasures Division, National Infection Service, London, UK.
  • Hallis B; Immunoassay Laboratory, National Infection Service, Porton Down, UK.
  • Stapley L; Immunoassay Laboratory, National Infection Service, Porton Down, UK.
  • Borrow R; Sero-epidemiology Unit, Public Health England, Public Health Laboratory Manchester, Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK.
  • Linley E; Sero-epidemiology Unit, Public Health England, Public Health Laboratory Manchester, Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK.
  • Ahmad S; Department of Virology, Manchester Medical Microbiology Partnership, Manchester Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
  • Parker B; The NIHR Manchester Clinical Research Facility, Manchester University NHS Foundation Trust, Manchester, UK.
  • Horsley A; Kellgren Centre for Rheumatology, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Amirthalingam G; The NIHR Manchester Clinical Research Facility, Manchester University NHS Foundation Trust, Manchester, UK.
  • Brown K; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
  • Ramsay ME; Immunisation and Countermeasures Division, National Infection Service, London, UK.
  • Ladhani S; Immunisation and Countermeasures Division, National Infection Service, London, UK.
  • Moss P; Immunisation and Countermeasures Division, National Infection Service, London, UK.
Nat Immunol ; 22(5): 620-626, 2021 05.
Article en En | MEDLINE | ID: mdl-33674800
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / SARS-CoV-2 / COVID-19 / Inmunidad Celular / Antígenos Virales Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / SARS-CoV-2 / COVID-19 / Inmunidad Celular / Antígenos Virales Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido